Name:
Adduct:
Polarity:
Z:
m/z:
±:
CCS: Å
±: %
SMI:
Type:

Make a CSV file containing information about your queries.
Then upload the CSV file below and click on "Make Queries" to view the results online
and click "Download Results" to download the entire results in one excel file.
An example of the CSV file can be found below

Download Example CSV


**Make sure the header column names are as follows**

...



Upload a CSV file

1
May, J. C. et al. Conformational Ordering of Biomolecules in the Gas Phase: Nitrogen Collision Cross Sections Measured on a Prototype High Resolution Drift Tube Ion Mobility-Mass Spectrometer. Anal. Chem. 86, 2107–2116 (2014).


2
Paglia, G. et al. Ion Mobility Derived Collision Cross Sections to Support Metabolomics Applications. Anal. Chem. 86, 3985–3993 (2014).


3
Groessl, M., Graf, S. & Knochenmuss, R. High resolution ion mobility-mass spectrometry for separation and identification of isomeric lipids. Analyst 140, 6904–6911 (2015).


4
Zhou, Z., Shen, X., Tu, J. & Zhu, Z.-J. Large-Scale Prediction of Collision Cross-Section Values for Metabolites in Ion Mobility-Mass Spectrometry. Anal. Chem. 88, 11084–11091 (2016).


5
Hines, K. M., Herron, J. & Xu, L. Assessment of altered lipid homeostasis by HILIC-ion mobility-mass spectrometry-based lipidomics. The Journal of Lipid Research 58, 809–819 (2017).


6
Bijlsma, L. et al. Prediction of Collision Cross-Section Values for Small Molecules: Application to Pesticide Residue Analysis. Anal. Chem. 89, 6583–6589 (2017).


7
Hines, K. M., Ross, D. H., Davidson, K. L., Bush, M. F. & Xu, L. Large-Scale Structural Characterization of Drug and Drug-Like Compounds by High-Throughput Ion Mobility-Mass Spectrometry. Anal. Chem. 89, 9023–9030 (2017).


8
Stow, S. M. et al. An Interlaboratory Evaluation of Drift Tube Ion Mobility–Mass Spectrometry Collision Cross Section Measurements. Anal. Chem. 89, 9048–9055 (2017).


9
Zhou, Z., Tu, J., Xiong, X., Shen, X. & Zhu, Z.-J. LipidCCS: Prediction of Collision Cross-Section Values for Lipids with High Precision To Support Ion Mobility–Mass Spectrometry-Based Lipidomics. Anal. Chem. 89, 9559–9566 (2017).


10
Zheng, X. et al. A structural examination and collision cross section database for over 500 metabolites and xenobiotics using drift tube ion mobility spectrometry. Chem. Sci. 8, 7724–7736 (2017).


11
Hines, K. M. et al. Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional Lipidomics. mSphere 2, 99–16 (2017).


12
Lian, R. et al. Ion mobility derived collision cross section as an additional measure to support the rapid analysis of abused drugs and toxic compounds using electrospray ion mobility time-of-flight mass spectrometry. Anal. Methods 10, 749–756 (2018).


13
Mollerup, C. B., Mardal, M., Dalsgaard, P. W., Linnet, K. & Barron, L. P. Prediction of collision cross section and retention time for broad scope screening in gradient reversed-phase liquid chromatography-ion mobility-high resolution accurate mass spectrometry. Journal of Chromatography A 1542, 82–88 (2018).


14
Righetti, L. et al. Ion mobility-derived collision cross section database: Application to mycotoxin analysis. Analytica Chimica Acta 1014, 50–57 (2018).


15
Tejada-Casado, C. et al. Collision cross section (CCS) as a complementary parameter to characterize human and veterinary drugs. Analytica Chimica Acta 1043, 52–63 (2018).


16
Nichols, C. M. et al. Untargeted Molecular Discovery in Primary Metabolism: Collision Cross Section as a Molecular Descriptor in Ion Mobility-Mass Spectrometry. Anal. Chem. 90, 14484–14492 (2018).


17
Hines, K. M. & Xu, L. Lipidomic consequences of phospholipid synthesis defects in Escherichia coli revealed by HILIC-ion mobility-mass spectrometry. Chemistry and Physics of Lipids 219, 15–22 (2019).


18
Leaptrot, K. L., May, J. C., Dodds, J. N. & McLean, J. A. Ion mobility conformational lipid atlas for high confidence lipidomics. Nature Communications 1–9 (2019).


19
Blaženović, I. et al. Increasing Compound Identification Rates in Untargeted Lipidomics Research with Liquid Chromatography Drift Time–Ion Mobility Mass Spectrometry. Anal. Chem. 90, 10758–10764 (2018).


20
Tsugawa, H. et al. MS-DIAL 4: accelerating lipidomics using an MS/MS, CCS, and retention time atlas. bioRxiv 37, 513 (2020).


21
Poland, J. C. et al. Collision Cross Section Conformational Analyses of Bile Acids via Ion Mobility–Mass Spectrometry. Journal of the American Society for Mass Spectrometry 31, 1625–1631 (2020).


22
Dodds, J. et al. Rapid Characterization of Per- and Polyfluoroalkyl Substances (PFAS) by Ion Mobility Spectrometry−Mass Spectrometry (IMS-MS). Anal. Chem. 92, 4427-4435 (2020).


23
Celma, A. et al. Improving Target and Suspect Screening High-Resolution Mass Spectrometry Workflows in Environmental Analysis by Ion Mobility Separation. Environ. Sci. Technol. 54, 15120-15131 (2020)


24
Belova, L. et al. Ion Mobility-High-Resolution Mass Spectrometry (IM-HRMS) for the Analysis of Contaminants of Emerging Concern (CECs): Database Compilation and Application to Urine Samples. Anal. Chem. XXX, XXXX-XXXX (2021)


25
Ross, D. H., et al. High-Throughput Measurement and Machine Learning-Based Prediction of Collision Cross Sections for Drugs and Drug Metabolites. J Am Soc Mass Spectr 33, 1061–1072 (2022).


26
EH Palm, J Engelhardt, S Tshepelevitsh, J Weiss, A Kruve (2024) J Am Soc Mass Spectrom DOI:10.1021/jasms.4c00035


27
Baker, E. S. et al. METLIN-CCS Lipid Database: An authentic standards resource for lipid classification and identification Nat. Metab. 6, 981-982 (2024).


28
HB Muller, G Scholl, J Far, E de Pauw, G Eppe (2023) Anal Chem 95(48): 17586-17594


29
Coming Soon...


ID Name Adduct Structure m/z CCS SMI Type Z Ref CCS Type CCS method
CCSBASE_d18a1ae933a5952de1763e7d79e17ff8 2S-OMPT [M+Na]+ 489.2410032 215.233333333 CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](COP(=S)(O)O)OC Lipids and lipid-like molecules 1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_571a1818beab2e621f69f3d25d4fa577 2S-OMPT [M+H]+ 467.25905927 221.066666667 CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](COP(=S)(O)O)OC Lipids and lipid-like molecules 1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_6b60d069b9f22e8c0e19359665c599cc 2S-OMPT [M+NH4]+ 484.2856066 220.733333333 CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](COP(=S)(O)O)OC Lipids and lipid-like molecules 1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_7b337d19280dae8bc88aa9bfa2f3b37b 3a,6a,7a,12a-tetrahydroxy bile acid (THBA) [M+Na]+ 447.2716944 197.7 C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@H]([C@@H]([C@@H]4[C@@]3(CC[C@H](C4)O)C)O)O)O)C Lipids and lipid-like molecules 1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_828f469c05cfaf01660b2847da612d9e 3a,6a,7a,12a-tetrahydroxy bile acid (THBA) [M+H]+ 425.28975047 201.766666667 C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@H]([C@@H]([C@@H]4[C@@]3(CC[C@H](C4)O)C)O)O)O)C Lipids and lipid-like molecules 1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_a85ddaa5021c4a218f61f290bf444627 3a,6a,7a,12a-tetrahydroxy bile acid (THBA) [M+NH4]+ 442.3162978 201.433333333 C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@H]([C@@H]([C@@H]4[C@@]3(CC[C@H](C4)O)C)O)O)O)C Lipids and lipid-like molecules 1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_8a7fd5235a08af69c45ad9488a94b6ce 3a,6a,7a,12a-tetrahydroxy bile acid (THBA) [M+H-H2O]+ 407.2791798 202.0 C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@H]([C@@H]([C@@H]4[C@@]3(CC[C@H](C4)O)C)O)O)O)C Lipids and lipid-like molecules 1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_240a60c89c88d3fcf68622f9b5b05e0f 3a,6a,7a,12a-tetrahydroxy bile acid (THBA) [M-H]- 423.275198 205.2 C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@H]([C@@H]([C@@H]4[C@@]3(CC[C@H](C4)O)C)O)O)O)C Lipids and lipid-like molecules -1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_c4b3a66b154ee288aef2dce4dc80fc5e 3a,6a,7a,12a-tetrahydroxy bile acid (THBA) [M+Cl]- 459.2518756 202.833333333 C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@H]([C@@H]([C@@H]4[C@@]3(CC[C@H](C4)O)C)O)O)O)C Lipids and lipid-like molecules -1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_00d381c38c59fb5f4e154350885a193f 3a,6a,7a,12a-tetrahydroxy bile acid (THBA) [M+HCOO]- 469.2806772 202.866666667 C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@H]([C@@H]([C@@H]4[C@@]3(CC[C@H](C4)O)C)O)O)O)C Lipids and lipid-like molecules -1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
1 2 ... 1818 1819 1820 1821 1822 1823 1824 ... 2315 2316